PLEASANTON, CA--(Marketwire - January 14, 2011) -
| Highlighted Links |
|
|
Callidus Software Inc. (NASDAQ: CALD), the leader in Sales Performance Management (SPM), announced today the formation of its CallidusRX division: a new packaged solution designed to address pharmaceutical commercial models in managing direct and intermediary sales channels. The division will be based in New York and will be led by Andrew Hahn, formerly Managing Partner of the Hahn Group.
“Andrew Hahn is one of the foremost experts in pharmaceutical sales performance solutions in the world,” said Leslie Stretch, president and CEO, Callidus Software. “We are delighted Mr. Hahn has joined us to lead this key Callidus business unit. The pharmaceutical market has unique needs in SPM. Our quota and territory planning, ranking, and commissions solutions are mission critical to sales growth in pharmaceutical businesses. The combination of our award-winning SaaS solutions and our new packaged services and BPO offering ensures that we are uniquely positioned for growth in this market.”
The announcement follows on from Callidus’ recent success in providing SaaS-based sales performance and commissions solutions to the pharmaceutical and life sciences market. Pharmaceutical companies have rigorous data and privacy requirements. Callidus’ standards-based, bullet-proof security, comprehensive auditability, and scalable Grid Computing architecture, coupled with its state-of-the-art SAS 70 Type II certified data centers, ensure the solution is uniquely positioned to meet the computing and regulatory needs of its pharmaceutical customers. Callidus now provides On Demand Sales Performance Management and Commissions solutions to 3 of the top 5 pharmaceutical companies in the world.
“Callidus is the clear market leader in pharmaceutical sales performance solutions,” said Andrew Hahn, Vice President, CallidusRX, Callidus Software. “Callidus continues to out-invest and out-innovate all comers in their quest to deliver unmatched value to companies in the sector. This new division will allow us to be even more effective in delivering high quality solutions to this market. I am delighted to be appointed to lead the CallidusRX division and look forward to building on the broad portfolio of technology and service solutions that we bring to the marketplace.”
Through the new business unit, Callidus extends its footprint to provide the most comprehensive offering of sales lifecycle management solutions in the pharmaceutical and life sciences industry. These solutions optimize sales force capacity planning, quota and territory planning, ranking, incentives and rewards, and sales talent optimization for pharmaceutical sales organizations. This gives customers the ability to align their sales force and channels with their key business objectives to consistently and reliably execute on sales targets.
About Callidus Software®
Callidus Software (NASDAQ: CALD) is the market and technology leader in Sales Performance Management (SPM). Callidus customers gain a competitive advantage by maximizing sales cost efficiencies and driving improvements in sales effectiveness. Our award-winning Software-as-a-Service (SaaS) applications set the standard for performance management of a company’s sales force and channel partners. Over 2 million employees and channel partners have their performance managed by Callidus Software. For more information, please visit www.callidussoftware.com.
Contact:
Rajendran Nair
Callidus Software Inc.
925-251-2255
pr@callidussoftware.com
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati: 
